Comparison of the manual mycobacteria growth indicator tube and the etest with the method of proportion for susceptibility testing of Mycobacterium tuberculosis

Chemotherapy

Volumn 52, Issue 4, 2006, Pages 174-177

  Fegou, E ^a   Jelastopulu, E ^a   Nicolaou, S ^b   Sevdali, M ^a   Anagnostou, S ^b   Kanavaki, S ^b   Dimitracopoulos, G ^a   Spiliopoulou, I ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b Athens Hospital for Chest Diseases   (Greece)

Author keywords

Antituberculous agents; Multidrug resistance; Mycobacterium tuberculosis; Susceptibility testing

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; HYBRIDIZATION; INTERMETHOD COMPARISON; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; MYCOBACTERIA GROWTH INDICATOR TUBE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 33745086343     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093035     Document Type: Article

References (14)

1. World Health Organization: Guidelines for the Surveillance of Drug-Resistance in Tuberculosis. WHO/TB/2003.320-WHO/CDS/CSR/ RMD/2003.3. Geneva, World Health Organization. 1997. http://www.who.int.
2. National Committee for Clinical Laboratory Standards: Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes. Tentative Standard M24-T2, ed 2. Wayne, National Committee for Clinical Laboratory Standards, 2000.
3. Rüsch-Gerdes S, Domehl C, Nardi G, Gismondo MR, Welscher HM, Pfyffer GE: Multicenter evaluation of the Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol 1999;37:45-48.
4. Cambau E, Truffot-Pernot C, Boulahbal F, Wichlacz C, Grosset J, Jarlier V: Mycobacteria Growth Indicator Tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2000;19:938-942.
5. Kontos F, Maniati M, Costopoulos C, Gitti Z, Nicolaou S, Petinaki E, Anagnostou S, Tselentis I, Maniatis AN: Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods 2004;56:291-294.
6. Joloba ML, Bajaksouzian S, Jacobs MR: Evaluation of the Etest for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2000;38:3834-3836.
7. Wanger A, Mills K: Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest. J Clin Microbiol 1996;34:1672-1676.
8. Akcali S, Cicek C, Surucuoglu S, Ozbakkaloglu B: E-test: An alternative method for susceptibility testing of Mycobacterium tuberculosis. Med Princ Pract 2005;14:264-267.
9. Fischer B: Epidemiology of mycobacterial resistance (especially Mycobacterium tuberculosis). Chemotherapy 1999;45:109-120.
10. Adjers-Koskela K, Katila ML: Susceptibility testing with the manual Mycobacteria Growth Indicator Tube (MGIT) and the MGIT 960 System provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 2003;41:1235-1239.
11. Bergmann JS, Woods GL: Reliability of Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin. J Clin Microbiol 1997;35:3325-3327.
12. Kocazeybek BS: Comparison of the BBL-Mycobacteria Growth Indicator Tube method with culture in the diagnosis of tuberculosis and evaluation of the resistance patterns of isolated strains to four major drugs. Chemotherapy 2002;48:64-70.
13. Di Perri G, Bonora S: Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemother 2004;54:593-602.
14. Iseman MD: Management of multidrug-resistant tuberculosis. Chemotherapy 1999;45(suppl 2):3-11.